Development of a Manufacturing Route to Avibactam, a β-Lactamase Inhibitor-Reference-Cited by-同舟云学术

Development of a Manufacturing Route to Avibactam, a β-Lactamase Inhibitor

Published:2016-09-27 Issue:10 Volume:20 Page:1799-1805
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Ball Matthew¹,Boyd Alistair¹,Ensor Gareth J.¹,Evans Matthew¹,Golden Michael¹,Linke Simon R.¹,Milne David¹,Murphy Rebecca¹,Telford Alex¹,Kalyan Yuriy²,Lawton Graham R.²,Racha Saibaba²,Ronsheim Melanie²,Zhou Shao Hong²

Affiliation:

1. Pharmaceutical Technology and Development, AstraZeneca, Silk Road Business Park, Macclesfield SK10 2NA, United Kingdom

2. Chemical Development, Forest Laboratories Inc., 45 Adams Avenue, Hauppauge, New York 1178, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.6b00268

Reference9 articles.

1. Aszodi, J., Fromentin, C., Lampilas, M., and Rowland, D.WO20033063864, 2003.

2. In vitro activity of AVE1330A, an innovative broad-spectrum non- -lactam -lactamase inhibitor

3. Using the Right Green Yardstick: Why Process Mass Intensity Is Used in the Pharmaceutical Industry To Drive More Sustainable Processes

4. Priour, A.; Bonnet, A.; Oddon, G.; Mazurie, A.WO2009090320, 2009.

5. Lampilas, M.; Aszodi, J.; Rowlands, D. A.; Fromentin, C.WO2002010172, 2002.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review;Pharmaceuticals;2024-08-23

2. Advances in polymeric and non-polymeric nanocarriers for the magnified delivery of levofloxacin against bacterial infection;Journal of Nanoparticle Research;2024-08

3. Chemical approaches to the sulfation of small molecules: current progress and future directions;Essays in Biochemistry;2024-07-03

4. A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli;Frontiers in Cellular and Infection Microbiology;2024-04-04

5. Synthesis and characterization of four diastereomers of β-lactamase inhibitor drug intermediate;Synthetic Communications;2023-12-05